PSMA PET improves characterization of dural-based intracranial lesions in patients with metastatic prostate cancer.

Divya YadavSilvina P DutruelElisabeth O'DwyerAndres Ricaurte-FajardoRituraj UpadhyayJoshua D PalmerSusan C PannulloScott T TagawaJonathan P S KniselyAndrew BrandmaierJoseph R OsborneJana Ivanidze

Published in: European journal of radiology (2024)

PSMA PET has the potential to differentiate meningiomas from dural-based metastases in patients with PCa, which can optimize clinical management and thus improve patient outcomes.

Keyphrases

pet ct
prostate cancer
pet imaging
positron emission tomography
radical prostatectomy
computed tomography
human health
optical coherence tomography